Potential role of bone morphogenetic protein (BMP) signalling as a potential therapeutic target for modification of iron balance

Nephrology Dialysis Transplantation

Volumn 24, Issue 1, 2009, Pages 28-30

  Browne, Sarah A ^a   Reddan, Donal ^a,b  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^b Merlin Park University Hospital   (Ireland)

Author keywords

Anaemia of chronic disease; Bone morphogenetic proteins; Hepcidin; Iron metabolism; Soluble haemojuvelin

Indexed keywords

BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 2; HEPCIDIN; IRON;

CHRONIC KIDNEY DISEASE; HEMOSTASIS; HUMAN; IRON BALANCE; IRON METABOLISM; IRON THERAPY; IRON TRANSPORT; NEPHROLOGIST; NOTE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANEMIA; ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; BONE MORPHOGENETIC PROTEINS; HEMOCHROMATOSIS; HOMEOSTASIS; HUMANS; IRON; MICE; RENAL INSUFFICIENCY, CHRONIC;

EID: 58049208289     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfn551     Document Type: Note

References (33)

1. Ganz T. Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood 2003; 102: 783-788
2. Nemeth E, Rivera S, Gabayan V et al. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest 2004; 113: 1271-1276
3. Nemeth E, Tuttle MS, Powelson J et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 2004; 306: 2090-2093
4. Rivera S, Nemeth E, Gabayan V et al. Synthetic hepcidin causes rapid dose-dependent hypoferremia and is concentrated in ferroportin-containing organs. Blood 2005; 106: 2196-2199
5. Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med 2005; 352: 1011-1023
6. Papanikolaou G, Tzilianos M, Christakis JI et al. Hepcidin in iron overload disorders. Blood 2005; 105: 4103-4105
7. Babitt JL, Huang FW, Wrighting DM et al. Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression. Nat Genet 2006; 38: 531-539
8. Babitt JL, Huang FW, Xia Y et al.Modulation of bone morphogenetic protein signaling in vivo regulates systemic iron balance. J Clin Invest 2007; 117: 1933-1939
9. Andrews NC. Anemia of inflammation: the cytokine-hepcidin link. J Clin Invest 2004; 113: 1251-1253
10. Nemeth E, Preza GC, Jung CL et al. The N-terminus of hepcidin is essential for its interaction with ferroportin: structure-function study. Blood 2006; 107: 328-333
11. Nemeth E, Valore EV, Territo M et al. Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood 2003; 101: 2461-2463
12. Ganz T. Hepcidin in iron metabolism. Curr Opin Hematol 2004; 11: 251-254
13. Dallalio G, Fleury T, Means RT. Serum hepcidin in clinical specimens. Br J Haematol 2003; 122: 996-1000
14. Kemna E, Tjalsma H, Laarakkers C et al. Novel urine hepcidin assay by mass spectrometry. Blood 2005; 106: 3268-3270
15. Park CH, Valore EV, Waring AJ et al. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem 2001; 276: 7806-7810
16. Nicolas G, Bennoun M, Devaux I et al. Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice. Proc Natl Acad Sci USA 2001; 98: 8780-8785
17. Nicolas G, Bennoun M, Porteu A et al. Severe iron deficiency anemia in transgenic mice expressing liver hepcidin. Proc Natl Acad Sci USA 2002; 99: 4596-4601
18. Nicolas G, Chauvet C, Viatte L et al. The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J Clin Invest 2002; 110: 1037-1044
19. Raja KB, Latunde-Dada GO, Peters TJ et al. Role of interleukin-6 in hypoxic regulation of intestinal iron absorption. Br J Haematol 2005; 131: 656-662
20. Lee P, Peng H, Gelbart T et al. Regulation of hepcidin transcription by interleukin-1 and interleukin-6. Proc Natl Acad Sci USA 2005; 102: 1906-1910
21. Wang RH, Li C, Xu X et al. A role of SMAD4 in iron metabolism through the positive regulation of hepcidin expression. Cell Metab 2005; 2: 399-409
22. Silvestri L, Pagani A, Camaschella C. Furin mediated release of soluble hemojuvelin: a new link between hypoxia and iron homeostasis. Blood 2008; 111: 924-931
23. Silvestri L, Pagani A, Fazi C et al. Defective targeting of hemojuvelin to plasma membrane is a common pathogenetic mechanism in juvenile hemochromatosis. Blood 2007; 109: 4503-4510
24. Pietrangelo A, Caleffi A, Henrion J et al. Juvenile hemochromatosis associated with pathogenic mutations of adult hemochromatosis genes. Gastroenterology 2005; 128: 470-479
25. Roetto A, Daraio F, Porporato P et al. Screening hepcidin for mutations in juvenile hemochromatosis: identification of a new mutation (C70R). Blood 2004; 103: 2407-2409
26. Wallace DF, Dixon JL, Ramm GA et al. Hemojuvelin (HJV)-associated hemochromatosis: analysis of HJV and HFE mutations and iron overload in three families. Haematologica 2005; 90: 254-255
27. Coyne DW, Kapoian T, Suki W et al. Ferric gluconate is highly efficacious in anemic hemodialysis patients with high serum ferritin and low transferrin saturation: results of the Dialysis Patients' Response to IV Iron with Elevated Ferritin (DRIVE) Study. J Am Soc Nephrol 2007; 18: 975-984
28. KDOQI. Clinical Practice Guidelines and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease. Am J Kidney Dis 2006; 47: S11-S145
29. Fishbane S. Safety in iron management. Am J Kidney Dis 2003; 41: 18-26
30. Michael B. The safety of sodium ferric gluconate complex in haemodialysis patients has been extensively evaluated. Nephrol Dial Transplant 2005; 20: 1770
31. Gastaldello K, Vereerstraeten A, Nzame-Nze T et al. Resistance to erythropoietin in iron-overloaded haemodialysis patients can be overcome by ascorbic acid administration. Nephrol Dial Transplant 1995; 10(Suppl 6): 44-47
32. Cooper A, Mikhail A, Lethbridge MW et al. Pentoxifylline improves hemoglobin levels in patients with erythropoietin-resistant anemia in renal failure. J Am Soc Nephrol 2004; 15: 1877-1882
33. Ganz T. Hepcidin - a peptide hormone at the interface of innate immunity and iron metabolism. Curr Top Microbiol Immunol 2006; 306: 183-198